ResMed Warns Customers of Potential Magnetic Interference from Masks

🌧️Trending News

RESMED ($NYSE:RMD) Inc is a leading medical technology company that develops, manufactures, and distributes innovative connected healthcare devices, software, and services to improve patient outcomes. Recently, ResMed has issued a warning to customers about potential magnetic interference from masks. This is due to certain types of masks containing magnets that may interfere with medical equipment. ResMed urges customers to check that any mask they use is compatible with the equipment they are using. Customers should also be aware of any other products or items that may cause interference, such as cell phones, credit cards, and certain jewelry. If a customer experiences any interference, they should contact ResMed customer service immediately.

ResMed is committed to providing customers with the best possible experience. The company is dedicated to continuously improving its products and services to ensure that customers receive the highest quality care. They are also committed to educating customers on the potential risks associated with using masks and other equipment. Customers should take the time to understand these risks and be aware of any potential risks associated with their equipment.

Price History

RESMED INC stock opened at $173.9 and closed at $174.0, up by 0.2% from prior closing price of 173.6. The company noted that its masks may be affected by certain external magnetic fields that could interfere with the working of the masks. As such, it advised customers to avoid exposure to such fields while wearing the masks. RESMED INC also stated that it is committed to ensuring the safety and efficacy of its products and will take necessary steps to address the issue. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Resmed Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Resmed Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Resmed Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Resmed Inc are shown below. More…

Analysis

At GoodWhale, we recently conducted an analysis of RESMED INC‘s fundamentals. The results of our Star Chart showed that RESMED INC has a high health score of 9/10, which means its cashflows and debt are healthy, allowing it to safely ride out any crisis without the risk of bankruptcy. We classified RESMED INC as a ‘gorilla’, a type of company that has achieved stable and high revenue or earning growth due to its strong competitive advantage. When considering what kind of investors would be interested in such a company, RESMED INC stands out for its strength in dividend, growth, profitability, and medium in asset. It is clear that RESMED INC is a strong company with robust fundamentals, making it an attractive opportunity for investors who are looking for a company with reliable long-term growth potential. We are confident that this analysis will help investors make more informed decisions. More…

Peers

ResMed’s competitors include Natus Medical Inc, Sanara MedTech Inc, and Avita Corp.

– Natus Medical Inc ($NASDAQ:SMTI)

As of 2022, Sanara MedTech Inc has a market cap of 227.36M and a Return on Equity of -22.91%. The company is a medical device company that develops and manufactures products for the treatment of chronic wounds and other conditions.

– Sanara MedTech Inc ($TPEX:4735)

Avita Corp is a biotechnology company that develops, manufactures, and markets products based on regenerative medicine. The company’s products are used to treat a variety of conditions, including burns, wounds, and skin diseases. Avita’s products are sold in over 30 countries worldwide. The company has a market cap of 1.21B as of 2022 and a return on equity of 9.62%.

Summary

RESMED Inc is a global medical equipment firm that designs, manufactures, distributes and markets products for the treatment of sleep apnea. Investing in RESMED Inc could be a sound decision. The company has been growing rapidly, as evidenced by its financial performance in the last five years. Furthermore, the company has consistently paid dividends over the past five years, which has provided investors with steady income.

Additionally, RESMED Inc has a strong balance sheet with more than $1 billion in cash and liquid assets, and low debt levels. Lastly, the company has a strong competitive advantage in its industry, giving it a strong position to continue its success in the future.